A new pharmacological method of host conditioning in order to facilitate in vivo growth of fibroblast-like cells cultivated in vitro.
D000818:Animals; D001215:Asparaginase / Q000008:administration & dosage / Q000494:pharmacology*; D001391:Azo Compounds / Q000494:pharmacology*; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D005260:Female; D005347:Fibroblasts / Q000637:transplantation*; D005998:Glycine / Q000494:pharmacology*; D006084:Graft Rejection / Q000187:drug effects*; D007166:Immunosuppressive Agents; D008221:Lymphoid Tissue / Q000187:drug effects; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology*
D001391:Azo Compounds; D007166:Immunosuppressive Agents; D001215:Asparaginase; D005998:Glycine